放Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification

BACKGROUND: Pemetrexed/platinum chemotherapy has been the standard chemotherapy regimen for lung adenocarcinoma patients, but the efficacy varies considerably. METHODS: To discover new serum biomarkers to predict the efficacy of pemetrexed/platinum chemotherapy, we analyzed 20 serum samples from adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Bo, Zhao, Xinghui, Wu, Di, Dong, Zhi, Chi, Yujia, Zhao, Jun, Wu, Meina, An, Tongtong, Wang, Yuyan, Zhuo, Minglei, Li, Jianjie, Chen, Xiaoling, Tian, Guangming, Long, Jieran, Yang, Xue, Chen, Hanxiao, Wang, Jingjing, Zhai, Xiaoyu, Li, Sheng, Li, Junfeng, Ma, Menglei, He, Yuling, Kong, Lingdong, Brcic, Luka, Fang, Jian, Wang, Ziping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947410/
https://www.ncbi.nlm.nih.gov/pubmed/33718037
http://dx.doi.org/10.21037/tlcr-21-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947410/
https://www.ncbi.nlm.nih.gov/pubmed/33718037
http://dx.doi.org/10.21037/tlcr-21-153

Ejemplares similares